FindTrial
Sign In

roxadustat 50 mg,Standard Medical Treatment

2 trials

Sponsors

Bangabandhu Sheikh Mujib Medical University

Conditions

Cirrhosis of liver patients who is anemic Anemia, Cirrhosis of Liver, Treatment with Roxadustat a hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitorCirrhosis of liver patients who is anemic Anemia, Cirrhosis of Liver, Treatment with Roxadustat a hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor, lipid profile

Phase 2

Effect of Roxadustat in management of anemia and iron regulation in cirrhosis of liver patients
Active, not recruitingTCTR20230615001
Bangabandhu Sheikh Mujib Medical UniversityCirrhosis of liver patients who is anemic Anemia, Cirrhosis of Liver, Treatment with Roxadustat a hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor
Start: 2023-07-10Target: 90Updated: 2026-08-03
Changes in lipid profile after roxadustat treatment in cirrhosis of liver patients ; A randomized control trial
Active, not recruitingTCTR20230710002
Bangabandhu Sheikh Mujib Medical UniversityCirrhosis of liver patients who is anemic Anemia, Cirrhosis of Liver, Treatment with Roxadustat a hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor, lipid profile
Start: 2023-07-07Target: 105Updated: 2026-08-03